Publications of Institute of Radiopharmaceutical Cancer Research - Year 2023
13 Publications2023
Preparation of 18F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [18F]Fluoride Exchange Reaction
Craig, A.; Kogler, J.; Laube, M.; Ullrich, M.; Donat, C.; et al. (8 authors)
-
Pharmaceutics 15(2023)12, 2749
DOI: 10.3390/pharmaceutics15122749
Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment
Rodrigues Loureiro, L. R.; Hoffmann, L.; Neuber, C.; Rupp, L.; Arndt, C.; et al. (12 authors)
-
Journal of Experimental & Clinical Cancer Research 42(2023), 341
DOI: 10.1186/s13046-023-02912-w
Exploring the Potential of Nanogels: From Drug Carriers to Radiopharmaceutical Agents
Kubeil, M.; Suzuki, Y.; Casulli, M. A.; Kamal, R.; Hashimoto, T.; et al. (8 authors)
-
Advanced Healthcare Materials 13(2023)1, 2301404
DOI: 10.1002/adhm.202301404
Bispidine Chelators for Radiopharmaceutical Applications with Lanthanide, Actinide and Main Group Metal Ions
Kopp, I.; Cieslik, P.; Anger, K.; Josephy, T.; Neupert, L.; et al. (15 authors)
-
Inorganic Chemistry 62(2023)50, 20754-20768
DOI: 10.1021/acs.inorgchem.3c02340
Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights Into Unforeseen Pharmacokinetics
Krutzek, F.; Donat, C.; Stadlbauer, S.
-
International Journal of Molecular Sciences 24(2023)20, 15088
DOI: 10.3390/ijms242015088
Design, Synthesis, and Biological Evaluation of Small Molecule Based Radioligands with Improved Pharmacokinetic Properties for Imaging of Programmed Death Ligand 1
Krutzek, F.; Donat, C.; Ullrich, M.; Stadlbauer, S.
-
Journal of Medicinal Chemistry 66(2023)23, 15894-15915
DOI: 10.1021/acs.jmedchem.3c01355
Equilibrium Thermodynamics of Macropa Complexes with Selected Metal Isotopes of Radiopharmaceutical Interest
Blei, M. K.; Waurick, L.; Reissig, F.; Kopka, K.; Stumpf, T.; et al. (8 authors)
-
Inorganic Chemistry 62(2023)50, 20699-20709
DOI: 10.1021/acs.inorgchem.3c01983
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1
Krutzek, F.; Donat, C.; Ullrich, M.; Zarschler, K.; Ludik, M.-C.; et al. (9 authors)
-
Cancers 15(2023), 2638
DOI: 10.3390/cancers15092638
Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5
Striese, F.; Neuber, C.; Gräßel, S.; Arndt, C.; Ullrich, M.; et al. (13 authors)
-
International Journal of Molecular Sciences 24(2023)11, 9420
DOI: 10.3390/ijms24119420
Cyclotron-based Production of 67Cu for Radionuclide Theranostics Via the 70Zn(p,α)67Cu Reaction
Brühlmann, S. A.; Walther, M.; Kreller, M.; Reissig, F.; Pietzsch, H.-J.; et al. (7 authors)
-
Pharmaceuticals 16(2023), 314
DOI: 10.3390/ph16020314
The Impact of Nε-Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2
Heerwig, A.; Kick, A.; Sommerfeld, P.; Eimermacher, S.; Hartung, F.; et al. (13 authors)
-
International Journal of Molecular Sciences 24(2023), 1650
DOI: 10.3390/ijms24021650
Copper-free click bioconjugation of technetium-99m complexes using strained cyclononyne derivatives
Schlesinger, M.; Jentschel, C.; Pietzsch, H.-J.; Kopka, K.; Mamat, C.
-
Dalton Transactions 52(2023), 3024-3032
DOI: 10.1039/D2DT03965F
Enzymological characterization of ⁶⁴Cu-labeled neprilysin substrates and their application for modulating the renal clearance of targeted radiopharmaceuticals
Brandt, F.; Ullrich, M.; Wodtke, J.; Kopka, K.; Bachmann, M.; et al. (9 authors)
-
Journal of Medicinal Chemistry 66(2023)1, 516-537
DOI: 10.1021/acs.jmedchem.2c01472
Years: 2024 2023 2022 2021 2020 2019
